India, Sept. 2 -- The following biotech stocks reached a 52-week high on September 1, 2026, as various companies reported financial results and reached certain regulatory milestones.
MiniMed Group Inc. (MMED)
MiniMed operates as a diabetes technology company, developing devices for insulin delivery, continuous glucose monitoring, software applications, and algorithms for hypoglycemic patients.
On Tuesday, the company saw shares rise to a 52-week high of $22.74 after rising over 10% in the intraday trade.
The company reported financial results for the full fiscal year of 2026 on Tuesday, noting a 16.6% growth in worldwide net sales amounting to $843 million, driven by an international sales gain of 18.1%.
Additionally, the company estim...